source
- ARPA-H launches Surpass program to speed and broaden clinical trialsThe U.S. Department of Health and Human Services announced a new initiative called Surpass, aimed at removing obstacles that slow clinical development and changing how trials are designed and run.…
- CAR-T biotech Caribou Biosciences halts two programs and seeks exit after funding shortfallCaribou Biosciences announced it is suspending two of its allogeneic CAR-T cell therapy projects. The company said it could not obtain the financing needed to keep the programs alive and is now lo…